Dept. of Clinical Psychology, Psychobiology and Methodology, Universidad de La Laguna Campus de Guajara, 38200, Tenerife, Spain.
Dept. of Clinical Psychology, Psychobiology and Methodology, Universidad de La Laguna Campus de Guajara, 38200, Tenerife, Spain.
Patient Educ Couns. 2020 Oct;103(10):2116-2131. doi: 10.1016/j.pec.2020.04.030. Epub 2020 May 7.
Psychopharmacological medication adherence is essential for psychiatric patients' treatment and well-being.
This review aimed to identify psychological factors related to health control that have been linked to psychopharmacological medication adherence in psychiatric patients.
A literature search was performed through the databases Medline, PubMed, PsycINFO, and Google Scholar to identify relevant studies published before October 15th, 2019. Articles published in peer-reviewed journals that analyzed the psychological factors of health belief and health control involved in psychopharmacological medication adherence in a psychiatric population were included.
The search identified 124 potentially relevant papers, 29 of which met the eligibility criteria. The final sample was 222 adolescents, most with a diagnosis of attention deficit/hyperactivity disorder (ADHD), and 6139 adults diagnosed especially with schizophrenia spectrum disorder, bipolar disorder, or depressive disorder. Results suggested that medication adherence is associated with health beliefs and psychological variables, such as self-efficacy and locus of control. Family support was also positively related to medication adherence.
Psychopharmacological medication adherence requires a consideration of multicausality, which depends on sociodemographic, clinical, and psychological factors.
These findings should be considered in the development and implementation of psychological interventions focused on self-control and family support.
精神科患者的治疗和福祉离不开精神药理学药物的坚持服用。
本综述旨在确定与健康控制相关的心理因素，这些因素与精神科患者的精神药理学药物坚持服用有关。
通过 Medline、PubMed、PsycINFO 和 Google Scholar 数据库进行文献检索，以确定 2019 年 10 月 15 日之前发表的相关研究。纳入了发表在同行评议期刊上的分析精神药理学药物坚持服用的健康信念和健康控制的心理因素的文章。
检索出 124 篇潜在相关文献，其中 29 篇符合入选标准。最终样本包括 222 名青少年，其中大多数患有注意力缺陷/多动障碍（ADHD），6139 名成年人，特别是患有精神分裂症谱系障碍、双相情感障碍或抑郁症。结果表明，药物坚持与健康信念和心理变量（如自我效能和控制源）有关。家庭支持也与药物坚持呈正相关。
精神药理学药物坚持需要考虑多因性，这取决于社会人口统计学、临床和心理因素。
在制定和实施注重自我控制和家庭支持的心理干预措施时，应考虑到这些发现。
